Compare VRDN & PAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | VRDN | PAX |
|---|---|---|
| Founded | 2006 | 1988 |
| Country | United States | Cayman Islands |
| Employees | N/A | N/A |
| Industry | Medical Specialities | Investment Managers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.7B | 2.2B |
| IPO Year | 2014 | 2020 |
| Metric | VRDN | PAX |
|---|---|---|
| Price | $30.42 | $12.47 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 13 | 1 |
| Target Price | ★ $41.17 | $20.00 |
| AVG Volume (30 Days) | ★ 1.2M | 1.0M |
| Earning Date | 05-25-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 4.82% |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $5,706,000.00 | N/A |
| Revenue This Year | $13.90 | $13.00 |
| Revenue Next Year | $284.55 | $15.87 |
| P/E Ratio | ★ N/A | $25.65 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $9.90 | $9.44 |
| 52 Week High | $34.29 | $17.80 |
| Indicator | VRDN | PAX |
|---|---|---|
| Relative Strength Index (RSI) | 52.88 | 24.54 |
| Support Level | $21.50 | $9.87 |
| Resistance Level | $33.71 | $14.53 |
| Average True Range (ATR) | 1.60 | 0.50 |
| MACD | 0.26 | -0.06 |
| Stochastic Oscillator | 92.69 | 9.40 |
Viridian Therapeutics Inc is a clinical-stage biopharmaceutical company that engages in developing multiple product candidates to treat patients who suffer from thyroid eye disease. Its product candidate includes Veligrotug (formerly known as VRDN-001) for intravenous (IV) and VRDN-003 for subcutaneous (SC) administration. Veligrotug is a differentiated humanized monoclonal antibody targeting IGF-1R intravenously administered for the treatment of thyroid eye disease (TED).
Patria Investments Ltd is an alternative asset management firm specializing in resilient sectors across select regions. It seeks to provide world-wide and Latin American investors with attractive investment products that allows portfolio diversification and consistent returns. The group promotes inclusive and sustainable development in the Asset Classes: Private Equity, Private Equity Solutions, Credit, Real Estate, Infrastructure, and Public Equities Main sectors: Agribusiness, Power & Energy, Healthcare, Logistics & Transportations, Food & Beverage and Digital & Tech Services Investment Regions.